Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Trop ; 122(1): 138-49, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22266119

ABSTRACT

The apicomplexan parasite Plasmodium vivax is responsible for causing more than 70% of human malaria cases in Central and South America, Southeastern Asia and the Indian subcontinent. The rising severity of the disease and the increasing incidences of resistance shown by this parasite towards usual therapeutic regimens have necessitated investigation of putative novel drug targets to combat this disease. The apicoplast, an organelle of procaryotic origin, and its circular genome carrying genes of possible functional importance, are being looked upon as potential drug targets. The genes on this circular genome are believed to be highly conserved among all Plasmodium species. Till date, the plastid genome of P. falciparum, P. berghei and P. chabaudi have been detailed while partial sequences of some genes from other parasites including P. vivax have been studied for identifying evolutionary positions of these parasites. The functional aspects and significance of most of these genes are still hypothetical. In one of our previous reports, we have detailed the complete sequence, as well as structural and functional characteristics of the Elongation factor encoding tufA gene from the plastid genome of P. vivax. We present here the sequences of large and small subunit rRNA (lsu and ssu rRNA) genes, sufB (ORF470) gene, RNA polymerase (rpo B, C) subunit genes and clpC (casienolytic protease) gene from the plastid genome of P. vivax. A comparative analysis of these genes between P. vivax and P. falciparum reveals approximately 5-16% differences. A codon usage analysis of major plastid genes has shown a high frequency of codons rich in A/T at any or all of the three positions in all the species. TTA, AAT, AAA, TAT, and ATA are the major preferred codons. The sequences, functional domains and structural analysis of respective proteins do not show any variations in the active sites. A comparative analysis of these Indian P. vivax plastid genome encoded genes has also been done to understand the evolutionary position of the Indian parasite in comparison to other Plasmodium species.


Subject(s)
DNA, Protozoan/genetics , Genes, Protozoan , Genome , Organelles/genetics , Plasmodium vivax/genetics , Codon , Conserved Sequence , DNA, Circular/chemistry , DNA, Circular/genetics , DNA, Protozoan/chemistry , India , Molecular Sequence Data , Plasmodium falciparum/genetics , Plasmodium vivax/isolation & purification , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid
2.
Exp Parasitol ; 119(1): 144-51, 2008 May.
Article in English | MEDLINE | ID: mdl-18343371

ABSTRACT

A number of stage-specific antigens have been characterized for vaccine development against Plasmodium falciparum malaria. This study presents a comprehensive analysis of the sequence polymorphism in Plasmodium falciparum apical membrane antigen-1 (PfAMA-1) in population samples from the eastern and western parts of India. This is the first study of its kind for the nearly full length PfAMA-1 gene from these regions in India. Our observations confirmed that sequence diversity of PfAMA-1 confines only to point mutations and shows 4-8% variation as compared to the prototypes. As opposed to the previous studies on PfAMA-1, our study revealed a greater degree of polymorphism in the Domain II region of PfAMA-1 protein, though signature for diversifying selection is seen throughout the gene. Our present investigation also indicates a very high degree of variation in the reported T- and B-cell epitopes of PfAMA-1. Few noteworthy and unique observations made in this study are the substitution of Cysteine residues responsible for the disulfide bond structure of the protein and the presence of premature termination after 595 amino acids in 3 of the 13 isolates under consideration. These crucial findings add new perspectives to the future of AMA-1 research and could have major implications in establishing AMA-1 as a vaccine candidate.


Subject(s)
Antigens, Protozoan/genetics , Membrane Proteins/genetics , Plasmodium falciparum/genetics , Polymorphism, Genetic , Protozoan Proteins/genetics , Amino Acid Sequence , Animals , Antigens, Protozoan/chemistry , Base Sequence , Cysteine/chemistry , DNA, Protozoan/blood , DNA, Protozoan/chemistry , Endemic Diseases , Epitopes, B-Lymphocyte/chemistry , Epitopes, B-Lymphocyte/genetics , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/genetics , Humans , India/epidemiology , Malaria Vaccines/chemistry , Malaria Vaccines/genetics , Malaria, Falciparum/epidemiology , Malaria, Falciparum/parasitology , Membrane Proteins/chemistry , Molecular Sequence Data , Plasmodium falciparum/immunology , Protozoan Proteins/chemistry , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...